Antipodes Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
United States Natural Gas Fund
UNG
|
+$23.6M |
| 2 |
Gilead Sciences
GILD
|
+$10.4M |
| 3 |
Baidu
BIDU
|
+$10.4M |
| 4 |
Cisco
CSCO
|
+$8.84M |
| 5 |
DYN
Dynegy, Inc.
DYN
|
+$8.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
|
+$2.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.46% |
| 2 | Financials | 20.96% |
| 3 | Communication Services | 16.33% |
| 4 | Consumer Discretionary | 14.76% |
| 5 | Healthcare | 9.84% |
Similar funds
Antipodes Partners's Q1 2017 Portfolio in Review
As of Q1 2017, Antipodes Partners held 24 positions worth $565M, up 27% from $445M the previous quarter. Its ten largest holdings account for 72% of the portfolio.
Antipodes Partners deployed $120M of net new capital in Q1 2017, opening 5 new positions and adding to 13 existing holdings. Its largest new stake was United States Natural Gas Fund: 194,943 shares worth $23.6M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the most notable exit was ProShares Trust UltraShort Lehman 20+ Year Treasury, an estimated $2.8M sold.
- Antipodes Partners's largest Q1 2017 buy was United States Natural Gas Fund: 194,943 shares worth $23.6M.
- Antipodes Partners added most to Gilead Sciences in Q1 2017, an estimated $10.4M increase.
- Antipodes Partners fully exited ProShares Trust UltraShort Lehman 20+ Year Treasury in Q1 2017, selling an estimated $2.8M.
- Antipodes Partners's ten largest holdings make up 72% of its $565M portfolio in Q1 2017.
- Antipodes Partners opened 5 new positions and closed 1 in Q1 2017.
- Antipodes Partners's portfolio value rose 27% quarter-over-quarter to $565M.
Based on Antipodes Partners's 13F filing for Q1 2017, filed 11 Apr 2017.